1
Kathryn S Prickett, Andrew A Young: Modified exendins and exendin agonists. Amylin Pharmaceuticals, Arnold & Porter, August 2, 2005: US06924264 (49 worldwide citation)

Novel modified exendins and exendin agonist analogs having an exendin or exendin agonist analog linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonist analog ...


2
Kathryn S Prickett, Andrew A Young: Exendins and exendin agonists modified with polyamino acids. Amylin Pharmaceuticals, Connolly Bove Lodge & Hutz, April 6, 2010: US07691963 (12 worldwide citation)

Modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more molecular weight increasing compounds, for example, polyamino acids, polyethylene glycol polymers, and related formulations and dosages and methods of administration thereof are provided. These modified ...


3
Kathryn S Prickett, Andrew A Young: Exendins and exendin agonists modified with albumin. Amylin Pharmaceuticals, Connolly Bove Lodge & Hutz, October 27, 2009: US07608692 (12 worldwide citation)

Modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods ...


4
Kathryn S Prickett, Andrew A Young: Modified exendins and exendin agonists. Amylin Pharmaceuticals, Connolly Bove Lodge & Hutz, November 15, 2011: US08057822 (11 worldwide citation)

Novel modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and m ...


5
Kathryn S Prickett, Andrew A Young: Methods of treating diabetes with albumin-conjugated exendin peptides. Amylin Pharmaceuticals, Connolly Bove Lodge & Hutz, March 23, 2010: US07683030 (11 worldwide citation)

Modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods ...


6
Kathryn S Prickett, Andrew A Young: Modified exendins and exendin agonists. Amylin Pharmaceuticals, AstraZeneca Pharmaceuticals, Womble Carlyle Sandridge & Rice, May 21, 2013: US08445647 (10 worldwide citation)

Novel modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and m ...


7
Young Andrew, Prickett Kathryn: Modified exendins and exendin agonists. Amylin Pharmaceuticals, January 30, 2002: EP1175443-A1 (3 worldwide citation)

Novel modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and m ...


8
Karthryn S Prickett, Andrew A Young: Modified exendins and exendin agonists. Amylin Pharmaceuticals, AstraZeneca Pharmaceuticals, Womble Carlyle Sandridge & Rice, February 10, 2015: US08951962

Novel modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and m ...


9
Kathryn S Prickett, Andrew A Young: Exendins and exendin agonists modified with polyamino acids. Amylin Pharmaceuticals, May 26, 2009: US07538186

Modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more molecular weight increasing compounds, for example, polyamino acids, polyethylene glycol polymers, and related formulations and dosages and methods of administration thereof are provided. These modified ...


10
Young Andrew, Prickett Kathryn: Modified exendins and exendin agonists. Amylin Pharmaceuticals, December 22, 2010: EP2264064-A1

Novel modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and m ...